Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Nilotinib | 10 | uM | 1 | 156.25 | 31.46 | 536.00 | 85.83 | 6.5543 | 7.8848 |
| MCF7 | Nilotinib | 19.9526 | uM | 1 | 156.25 | 31.46 | 3502.33 | 85.83 | 42.9134 | 38.9700 |
| MCF7 | PLX-4720 | 0.0033113 | uM | 1 | 156.25 | 31.46 | 122.33 | 85.83 | 1.3949 | 1.5008 |
| MCF7 | PLX-4720 | 0.01 | uM | 1 | 156.25 | 31.46 | 85.00 | 85.83 | 0.9516 | 0.8619 |
| MCF7 | PLX-4720 | 0.031623 | uM | 1 | 156.25 | 31.46 | 100.67 | 85.83 | 1.1908 | 1.2892 |
| MCF7 | PLX-4720 | 0.1 | uM | 1 | 156.25 | 31.46 | 58.33 | 85.83 | 0.7024 | 0.5678 |
| MCF7 | PLX-4720 | 0.31623 | uM | 1 | 156.25 | 31.46 | 84.00 | 85.83 | 0.9729 | 0.9536 |
| MCF7 | PLX-4720 | 1 | uM | 1 | 156.25 | 31.46 | 73.00 | 85.83 | 0.8969 | 0.9045 |
| MCF7 | PLX-4720 | 3.1623 | uM | 1 | 156.25 | 31.46 | 108.67 | 85.83 | 1.2726 | 1.3866 |
| MCF7 | PLX-4720 | 10 | uM | 1 | 156.25 | 31.46 | 101.00 | 85.83 | 1.2769 | 1.4348 |
| MCF7 | PLX-4720 | 19.9526 | uM | 1 | 156.25 | 31.46 | 86.33 | 85.83 | 1.0540 | 1.1467 |
| MCF7 | NVP-TAE684 | 0.0016596 | uM | 1 | 156.25 | 31.46 | 39.33 | 85.83 | 0.5303 | 0.2509 |
| MCF7 | NVP-TAE684 | 0.0033113 | uM | 1 | 156.25 | 31.46 | 81.67 | 85.83 | 0.9783 | 1.0069 |
| MCF7 | NVP-TAE684 | 0.01 | uM | 1 | 156.25 | 31.46 | 118.00 | 85.83 | 1.4022 | 1.6102 |
| MCF7 | NVP-TAE684 | 0.031623 | uM | 1 | 156.25 | 31.46 | 63.67 | 85.83 | 0.7706 | 0.6841 |
| MCF7 | NVP-TAE684 | 0.1 | uM | 1 | 156.25 | 31.46 | 50.67 | 85.83 | 0.6036 | 0.3997 |
| MCF7 | NVP-TAE684 | 0.31623 | uM | 1 | 156.25 | 31.46 | 32.33 | 85.83 | 0.3843 | 0.0102 |
| MCF7 | NVP-TAE684 | 1 | uM | 1 | 156.25 | 31.46 | 22.00 | 85.83 | 0.2617 | -0.2334 |
| MCF7 | NVP-TAE684 | 3.1623 | uM | 1 | 156.25 | 31.46 | 34.67 | 85.83 | 0.4320 | 0.1013 |
| MCF7 | NVP-TAE684 | 10 | uM | 1 | 156.25 | 31.46 | 26.00 | 85.83 | 0.3193 | -0.1298 |
| MCF7 | Palbociclib | 0.0033113 | uM | 1 | 156.25 | 31.46 | 77.33 | 70.42 | 1.1058 | 1.1877 |
| MCF7 | Palbociclib | 0.01 | uM | 1 | 156.25 | 31.46 | 63.00 | 70.42 | 0.9117 | 0.8741 |
| MCF7 | Palbociclib | 0.031623 | uM | 1 | 156.25 | 31.46 | 40.67 | 70.42 | 0.5911 | 0.2764 |
| MCF7 | Palbociclib | 0.1 | uM | 1 | 156.25 | 31.46 | 35.33 | 70.42 | 0.5150 | 0.1298 |
| MCF7 | Palbociclib | 0.31623 | uM | 1 | 156.25 | 31.46 | 64.67 | 70.42 | 0.9277 | 0.8914 |